At the 2025 annual meeting of the American Academy of Orthopedic Surgeons (AAOS), many device makers presented the newest generation of orthopedic robots. Prices of orthopedic robotic systems are expected to decline due to market competition, technological innovation, and economies of scale. In the next five years, the prices may drop 20-30 per cent as compact systems and competition expand, according to GlobalData.
According to GlobalData’s Global Brand Pricing product, the average cost of an orthopedic robotic system varies from $554,000 to over $1 million. Annual service costs are around 10 per cent of the system.
Tina Deng, MSc, Principal Medical Devices Analyst at GlobalData, comments, “Portable systems like Smith & Nephew’s CORI and Think Surgical’s TMINI are already reducing costs, while startups and emerging markets drive competition with affordable alternatives. Companies like Think Surgical and Korea-based Curexo have developed robotic systems that are compatible with implants from other manufacturers, which could further reduce the robotic procedure cost by choosing affordable knee or hip implants.”
Mass adoption—projected to grow the global market to $13 billion by 2030—will lower manufacturing costs, and subscription-based pricing models could replace upfront fees. Robotic orthopedic surgery, while initially expensive due to high upfront costs for systems and ongoing maintenance, demonstrates long-term cost-effectiveness. Enhanced precision in implant placement and alignment also lowers the need for costly revisions.
Additionally, streamlined workflows and value-based care models further improve economic viability by prioritising outcomes over volume. Regulatory support and insurer reimbursement for proven outcomes will accelerate affordability. However, challenges like surgeon training costs and persistent software upgrade expenses may delay accessibility in resource-limited settings.
Deng adds, “Long-term, robotics could become standard care, with costs nearing conventional tools due to AI-driven automation and scaled production. While affordability hinges on innovative pricing and healthcare policies, the trajectory suggests robotic surgery will transition from a premium option to a broadly accessible, cost-effective standard in orthopedics.